Skip to main content

Table 2 Clinical and laboratory measures in the three groups over 2 years in intention-to-treat (ITT) analysis and per-protocol (PP) analysis

From: Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study

Variables

Baseline

Year 2

ITT

PP

MTX (n = 69)

TwFH (n = 69)

TwFH + MTX (n = 69)

MTX (n = 69)

TwFH (n = 69)

TwFH + MTX (n = 69)

P

MTX (n = 14)

TwFH (n = 11)

TwFH + MTX (n = 22)

P

ESR (mm/h)

54.0 (28.0)

45.1 (24.6)

51.6 (25.9)

27.7 (22.6)

21.9 (17.9)

26.7 (27.3)

 

20.6 (16.8)

19.8 (19.0)

22.7 (26.4)

 

mean (SD)

54.0 (28.3, 77.0)

38.0 (26.0, 67.0)

48.2 (31.0, 72.0)

23.0 (10.0, 34.8)

15.0 (9.0, 31.0)

17.5 (9.0, 34.8)

0.760

17.0 (8.0, 27.3)

12.0 (5.0, 28.0)

15.5 (6.0, 28.5)

0.868

median (IQR)

CRP (mg/L)

mean (SD)

37.5 (40.4)

27.3 (25.0)

30.1 (28.7)

20.6 (34.6)

11.3 (20.7)

14.7 (28.6)

 

9.0 (18.4)

15.2 (37.7)

9.8 (20.3)

 

median (IQR)

21.7 (8.0, 53.8)

17.9 (7.0, 38.4)

24.8 (9.5, 42.6)

5.9 (1.4, 20.0)

3.5 (1.0, 12.7)

4.0 (2.0, 19.4)

0.803

1.7 (0.7, 9.4)

2.4 (0.7, 5.6)

3.7 (1.2, 9.1)

0.375

VAS (mm)

mean (SD)

71.4 (22.4)

68.5 (25.5)

70.5 (21.3)

36.8 (28.7)

32.1 (27.5)

36.7 (27.4)

 

33.2 (31.0)

29.1 (30.8)

33.6 (25.5)

 

median (IQR)

72.5 (50.0, 90.0)

70.0 (50.0, 95.0)

75.0 (50.0, 85.0)

30.0 (10.0, 57.5)

20.0 (10.0, 50.0)

32.5 (15.0, 60.0)

0.674

30.0 (7.5, 55.0)

20.0 (0, 50.0)

32.5 (7.5, 60.0)

0.966

PGA (mm)

mean (SD)

68.0 (24.6)

65.5 (23.6)

65.8 (21.3)

37.7 (27.5)

32.7 (27.6)

38.8 (25.9)

 

33.6 (27.6)

21.8 (24.4)

35.7 (25.7)

 

median (IQR)

70.0 (50.0, 87.5)

60.0 (50.0, 87.5)

62.5 (50.0, 80.0)

30.0 (10.0, 57.5)

25.0 (10.0, 50.0)

40.0 (18.8, 60.0)

0.959

30.0 (10.0, 50.0)

20.0 (0, 30.0)

37.5 (10.0, 60.0)

0.373

PhGA (mm)

mean (SD)

62.8 (23.5)

60.0 (23.7)

60.7 (23.1)

34.2 (27.7)

31.0 (26.6)

34.8 (26.1)

 

31.4 (32.3)

26.4 (26.9)

34.5 (26.8)

 

median (IQR)

65.0 (43.5, 80.0)

60.0 (40.0, 80.0)

60.0 (45.0, 80.0)

30.0 (10.0, 60.0)

20.0 (10.0, 50.0)

30.0 (10.0, 51.3)

0.826

30.0 (3.8, 55.0)

20.0 (0, 50.0)

32.5 (10.0, 60.0)

0.701

TJC

mean (SD)

16.2 (8.3)

13.8 (7.2)

15.5 (8.3)

6.9 (7.1)

4.5 (5.8)

6.3 (7.5)

 

6.1 (6.3)

2.5 (3.4)

0.9 (1.4)

 

median (IQR)

16.0 (7.5, 23.5)

13.0 (7.5, 17.0)

14.0 (8.0, 22.3)

5.0 (2.0, 10.0)

2.0 (0, 7.0)

3.0 (1.0, 9.0)

0.287

3.0 (1.0, 10.5)

2.0 (0, 5.0)

0 (0, 2.3)

0.368

SJC

mean (SD)

9.1(6.0)

8.9 (6.1)

8.9 (6.7)

2.9 (4.4)

2.5 (4.3)

2.4 (4.6)

 

3.1 (4.5)

0.3 (0.6)

2.2 (4.2)

 

median (IQR)

7.0 (4.5, 13.0)

7.0 (4.0, 12.0)

7.0 (3.0, 11.3)

2.0 (0, 4.0)

0 (0, 4.0)

0 (0, 3.0)

0.836

1.0 (0, 5.0)

0 (0, 0)

0 (0, 2.3)

0.191

HAQ

mean (SD)

1.5 (0.9)

1.3 (0.9)

1.4 (0.9)

1.2 (3.6)

0.5 (0.7)

0.6 (0.7)

 

2.6 (7.9)

0.4 (0.6)

0.6 (0.6)

 

median (IQR)

1.5 (0.9, 2.3)

1.3 (0.6, 2.0)

1.5 (0.6, 2.1)

0.5 (0, 1.3)

0.1 (0, 0.9)

0.4 (0, 1.0)

0.162

0.1 (0, 0.9)

0(0, 0.9)

0.5 (0.1, 1.1)

0.286

SF36

mean (SD)

237.8 (127.0)

292.6 (155.3)

279.1 (153.4)

388.8 (138.4)

448.9 (152.8)

417.2 (146.9)

 

453.3 (78.3)

469.7 (70.4)

445.1 (74.6)

 

median (IQR)

231.0 (143.8, 310.0)

269.3 (181.2, 406.4)

260.5 (163.5, 364.3)

397.5 (305.5, 489.5)

470.2 (351.3, 536.5)

411.8 (329.8, 507.3)

0.259

478.1 (373.6, 525.7)

493.3 (426.8, 509.7)

460.8 (397.8, 506.8)

0.609

DAS28

mean (SD)

6.62 (1.31)

6.22 (1.28)

6.38 (1.40)

4.16 (1.70)

3.54 (1.69)

3.95 (1.77)

 

3.82 (1.96)

2.83 (1.72)

3.58 (1.63)

 

median (IQR)

6.66 (5.48, 7.60)

6.16 (5.37, 7.06)

6.26 (5.47, 7.37)

3.70 (3.05, 5.12)

3.49 (2.09, 4.86)

3.89 (2.51, 5.13)

0.298

3.45 (2.71, 5.52)

2.40 (1.42, 4.49)

3.53 (2.01, 4.63)

0.613

  1. ESR erythrocyte sedimentation rate, CRP C-reactive protein, PGA Patient’s global assessment of disease activity, PhGA Physician’s global assessment of disease activity, TJC tender joint count, SJC swollen joint count, HAQ Health Assessment Questionnaire, SF-36 36-item Short-Form Health Survey questionnaire, DAS28 28-joint count Disease Activity Score, MTX methotrexate, TwHF Tripterygium wilfordii Hook F
  2. Data are presented as mean (standard deviation, SD) and median (interquartile range, IQR)
  3. The p values were calculated using the χ2 test